Interestingly, as illustrated in Fig. 5, LAV-BPIFB4 supplementation reduced the levels of IL-6, IL-8 and MCP-1 compared with the control, suggesting a crucial role of the protein in counteracting the immune dysfunction in IBD. This evidence concerns the gene BPIFB4 and inflammatory bowel disease.